Teva Sues Perrigo Over ProAir Generic Plans
Teva Pharmaceutical Industries Ltd. on Friday sued rival Perrigo Co. in Delaware federal court, alleging a planned generic version of asthma treatment ProAir HFA infringes several patents covering the drug and...To view the full article, register now.
Already a subscriber? Click here to view full article